{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:49:39Z","timestamp":1789001379896,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03268-7","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T13:02:20Z","timestamp":1724936540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Benvitimod upregulates filaggrin, involucrin and loricrin expressions via aryl hydrocarbon receptor-OVO-like 1 axis"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-8203","authenticated-orcid":false,"given":"Qiuyu","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6102-5028","authenticated-orcid":false,"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2616-3196","authenticated-orcid":false,"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1847-1404","authenticated-orcid":false,"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9321-1226","authenticated-orcid":false,"given":"Jun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-682X","authenticated-orcid":false,"given":"Jianzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1446-3466","authenticated-orcid":false,"given":"Houmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"5","key":"3268_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","volume":"151","author":"CFt Schuler","year":"2023","unstructured":"Schuler CFt et al (2023) Novel insights into atopic dermatitis. J Allergy Clin Immunol 151(5):1145\u20131154","journal-title":"J Allergy Clin Immunol"},{"key":"3268_CR2","doi-asserted-by":"crossref","unstructured":"Sroka-Tomaszewska J, Trzeciak M (2021) Molecular mechanisms of atopic Dermatitis Pathogenesis. Int J Mol Sci, 22(8)","DOI":"10.3390\/ijms22084130"},{"issue":"12","key":"3268_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S Stander","year":"2021","unstructured":"Stander S (2021) Atopic dermatitis. N Engl J Med 384(12):1136\u20131143","journal-title":"N Engl J Med"},{"issue":"3","key":"3268_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","volume":"61","author":"H Li","year":"2021","unstructured":"Li H et al (2021) Update on the Pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol 61(3):324\u2013338","journal-title":"Clin Rev Allergy Immunol"},{"key":"3268_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1749-6632.1985.tb50420.x","volume":"455","author":"BA Dale","year":"1985","unstructured":"Dale BA, Resing KA, Lonsdale-Eccles JD (1985) Filaggrin: a keratin filament associated protein. Ann N Y Acad Sci 455:330\u2013342","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3268_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0022-2836(83)80126-0","volume":"170","author":"CR Harding","year":"1983","unstructured":"Harding CR, Scott IR (1983) Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol 170(3):651\u2013673","journal-title":"J Mol Biol"},{"issue":"2","key":"3268_CR7","first-page":"917","volume":"123","author":"EH van den Bogaard","year":"2013","unstructured":"van den Bogaard EH et al (2013) Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Invest 123(2):917\u2013927","journal-title":"J Clin Invest"},{"issue":"3","key":"3268_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","volume":"126","author":"BE Kim","year":"2008","unstructured":"Kim BE et al (2008) Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 126(3):332\u2013337","journal-title":"Clin Immunol"},{"issue":"6","key":"3268_CR9","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","volume":"138","author":"H Esaki","year":"2016","unstructured":"Esaki H et al (2016) Early-onset pediatric atopic dermatitis is T(H)2 but also T(H)17 polarized in skin. J Allergy Clin Immunol 138(6):1639\u20131651","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"3268_CR10","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","volume":"210","author":"M Salimi","year":"2013","unstructured":"Salimi M et al (2013) A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210(13):2939\u20132950","journal-title":"J Exp Med"},{"key":"3268_CR11","doi-asserted-by":"crossref","unstructured":"Furue M (2020) Regulation of skin barrier function via competition between AHR Axis versus IL-13\/IL-4JAKSTAT6\/STAT3 Axis: pathogenic and therapeutic implications in atopic dermatitis. J Clin Med, 9(11)","DOI":"10.3390\/jcm9113741"},{"issue":"34","key":"3268_CR12","doi-asserted-by":"publisher","first-page":"13921","DOI":"10.1073\/pnas.1307321110","volume":"110","author":"Y Imai","year":"2013","unstructured":"Imai Y et al (2013) Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A 110(34):13921\u201313926","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3268_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaad.2018.06.047","volume":"80","author":"J Peppers","year":"2019","unstructured":"Peppers J et al (2019) A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis. J Am Acad Dermatol 80(1):89\u201398e3","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3268_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaad.2020.05.135","volume":"84","author":"AS Paller","year":"2021","unstructured":"Paller AS et al (2021) Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis. J Am Acad Dermatol 84(3):632\u2013638","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"3268_CR15","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","volume":"137","author":"SH Smith","year":"2017","unstructured":"Smith SH et al (2017) Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans. J Invest Dermatol 137(10):2110\u20132119","journal-title":"J Invest Dermatol"},{"key":"3268_CR16","doi-asserted-by":"publisher","first-page":"745997","DOI":"10.3389\/fimmu.2022.745997","volume":"13","author":"G Tsuji","year":"2022","unstructured":"Tsuji G et al (2022) Natural compounds Tapinarof and Galactomyces Ferment Filtrate Downregulate IL-33 expression via the AHR\/IL-37 Axis in Human keratinocytes. Front Immunol 13:745997","journal-title":"Front Immunol"},{"key":"3268_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-immunol-032713-120245","volume":"32","author":"B Stockinger","year":"2014","unstructured":"Stockinger B et al (2014) The aryl hydrocarbon receptor: multitasking in the immune system. Annu Rev Immunol 32:403\u2013432","journal-title":"Annu Rev Immunol"},{"key":"3268_CR18","doi-asserted-by":"crossref","unstructured":"Fernandez-Gallego N, Sanchez-Madrid F, Cibrian D (2021) Role of AHR Ligands in skin homeostasis and cutaneous inflammation. Cells, 10(11)","DOI":"10.3390\/cells10113176"},{"key":"3268_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mehy.2018.05.001","volume":"116","author":"M Napolitano","year":"2018","unstructured":"Napolitano M, Patruno C (2018) Aryl hydrocarbon receptor (AhR) a possible target for the treatment of skin disease. Med Hypotheses 116:96\u2013100","journal-title":"Med Hypotheses"},{"issue":"11","key":"3268_CR20","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jid.2016.06.627","volume":"136","author":"K Haas","year":"2016","unstructured":"Haas K et al (2016) Aryl Hydrocarbon receptor in Keratinocytes is essential for murine skin Barrier Integrity. J Invest Dermatol 136(11):2260\u20132269","journal-title":"J Invest Dermatol"},{"issue":"6","key":"3268_CR21","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jid.2020.10.025","volume":"141","author":"P Sun","year":"2021","unstructured":"Sun P et al (2021) OVOL1 regulates Psoriasis-Like skin inflammation and Epidermal Hyperplasia. J Invest Dermatol 141(6):1542\u20131552","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3268_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jdermsci.2018.02.005","volume":"90","author":"G Tsuji","year":"2018","unstructured":"Tsuji G et al (2018) The role of the OVOL1-OVOL2 axis in normal and diseased human skin. J Dermatol Sci 90(3):227\u2013231","journal-title":"J Dermatol Sci"},{"key":"3268_CR23","doi-asserted-by":"crossref","unstructured":"Hashimoto-Hachiya A et al (2018) Upregulation of FLG, LOR, and IVL expression by Rhodiola Crenulata Root Extract via Aryl Hydrocarbon receptor: Differential involvement of OVOL1. Int J Mol Sci, 19(6)","DOI":"10.3390\/ijms19061654"},{"issue":"7","key":"3268_CR24","doi-asserted-by":"publisher","first-page":"e2931","DOI":"10.1038\/cddis.2017.322","volume":"8","author":"G Tsuji","year":"2017","unstructured":"Tsuji G et al (2017) Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis. Cell Death Dis 8(7):e2931","journal-title":"Cell Death Dis"},{"key":"3268_CR25","doi-asserted-by":"crossref","unstructured":"Furue M, Hashimoto-Hachiya A, Tsuji G (2019) Aryl Hydrocarbon Receptor in atopic dermatitis and psoriasis. Int J Mol Sci, 20(21)","DOI":"10.3390\/ijms20215424"},{"key":"3268_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4939-6786-5_8","volume":"1559","author":"V Moosbrugger-Martinz","year":"2017","unstructured":"Moosbrugger-Martinz V, Schmuth M, Dubrac S (2017) A mouse model for atopic dermatitis using topical application of vitamin D3 or of its Analog MC903. Methods Mol Biol 1559:91\u2013106","journal-title":"Methods Mol Biol"},{"issue":"31","key":"3268_CR27","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.1073\/pnas.0604575103","volume":"103","author":"M Li","year":"2006","unstructured":"Li M et al (2006) Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A 103(31):11736\u201311741","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3268_CR28","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jaci.2018.11.036","volume":"143","author":"J Yu","year":"2019","unstructured":"Yu J et al (2019) A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor. J Allergy Clin Immunol 143(6):2108\u20132119e12","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3268_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jid.2021.05.033","volume":"142","author":"X Dai","year":"2022","unstructured":"Dai X et al (2022) Nuclear IL-33 plays an important role in IL-31Mediated downregulation of FLG, Keratin 1, and Keratin 10 by Regulating Signal Transducer and activator of transcription 3 activation in human keratinocytes. J Invest Dermatol 142(1):136\u2013144e3","journal-title":"J Invest Dermatol"},{"issue":"4","key":"3268_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/imm.13120","volume":"158","author":"K Furue","year":"2019","unstructured":"Furue K et al (2019) The IL-13-OVOL1-FLG axis in atopic dermatitis. Immunology 158(4):281\u2013286","journal-title":"Immunology"},{"issue":"3","key":"3268_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jdermsci.2023.06.008","volume":"111","author":"B Nasanbat","year":"2023","unstructured":"Nasanbat B et al (2023) Kaempferol therapy improved MC903 induced-atopic dermatitis in a mouse by suppressing TSLP, oxidative stress, and type 2 inflammation. J Dermatol Sci 111(3):93\u2013100","journal-title":"J Dermatol Sci"},{"issue":"1","key":"3268_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/jid.2010.277","volume":"131","author":"M Hvid","year":"2011","unstructured":"Hvid M et al (2011) IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131(1):150\u2013157","journal-title":"J Invest Dermatol"},{"issue":"170","key":"3268_CR33","doi-asserted-by":"publisher","first-page":"170ra16","DOI":"10.1126\/scitranslmed.3005374","volume":"5","author":"BS Kim","year":"2013","unstructured":"Kim BS et al (2013) TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5(170):170ra16","journal-title":"Sci Transl Med"},{"issue":"3","key":"3268_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","volume":"19","author":"V Rothhammer","year":"2019","unstructured":"Rothhammer V, Quintana FJ (2019) The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat Rev Immunol 19(3):184\u2013197","journal-title":"Nat Rev Immunol"},{"issue":"Pt 23","key":"3268_CR35","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1242\/jcs.03282","volume":"119","author":"S Geng","year":"2006","unstructured":"Geng S et al (2006) Targeted ablation of Arnt in mouse epidermis results in profound defects in desquamation and epidermal barrier function. J Cell Sci 119(Pt 23):4901\u20134912","journal-title":"J Cell Sci"},{"key":"3268_CR36","doi-asserted-by":"crossref","unstructured":"Loertscher JA et al (2002) In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin causes accelerated terminal differentiation in fetal mouse skin Toxicol Sci, 68(2): pp. 465\u2009\u2013\u200972","DOI":"10.1093\/toxsci\/68.2.465"},{"issue":"3","key":"3268_CR37","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jid.2023.07.027","volume":"144","author":"X Wang","year":"2024","unstructured":"Wang X et al (2024) Benvitimod inhibits IL-4- and IL-13-Induced tight Junction impairment by activating AHR\/ARNT pathway and inhibiting STAT6 phosphorylation in human keratinocytes. J Invest Dermatol 144(3):509\u2013519e7","journal-title":"J Invest Dermatol"},{"key":"3268_CR38","doi-asserted-by":"crossref","unstructured":"Yang G et al (2020) Skin barrier abnormalities and Immune Dysfunction in atopic dermatitis. Int J Mol Sci, 21(8)","DOI":"10.3390\/ijms21082867"},{"key":"3268_CR39","doi-asserted-by":"crossref","unstructured":"Vu YH et al (2020) IL-24 negatively regulates keratinocyte differentiation Induced by Tapinarof, an aryl hydrocarbon receptor modulator: implication in the treatment of atopic dermatitis. Int J Mol Sci, 21(24)","DOI":"10.3390\/ijms21249412"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03268-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:09:43Z","timestamp":1729699783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03268-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3268"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03268-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}